已核实 DOI PubMed 相关产品: 204

Near-infrared-traceable DNA nano-hydrolase: specific eradication of telomeric G-overhang in vivo

Journal 2020 · IF 11.502 · 48(17): 9986-9994 · 发表于 2020 年 8 月 27 日
作者: Sun Yuhuan,Zhao Chuanqi,Cui Tingting,Qin Hongshuang,Niu Jingsheng,Ren Jinsong,Qu Xiaogang
阅读全文 在 PubMed 查看

摘要

Telomeric DNA, whose length homeostasis is closely correlated with immortality of cancer cells, is regarded as a molecular clock for cellular lifespan. Regarding the capacity in forming G-quadruplex, G-rich 3′-overhang (G-overhang) has been considered as an attractive anticancer target. However, it is still challenging to precisely target telomeric G-overhang with current ligands because of the polymorphism of G-quadruplexes in cells. Herein, we construct a telomeric G-overhang-specific near-infrared-traceable DNA nano-hydrolase, which is composed of four parts: (i) dexamethasone for targeting cell nuclei; (ii) complementary DNA for hybridizing with G-overhang; (iii) multinuclear Ce(IV) complexes for hydrolyzing G-overhang; and (iv) upconversion nanoparticles for real-time tracking. The multivalent targeted DNA nano-hydrolase can be traced to precisely digest telomeric G-overhang, which contributes to telomeric DNA shortening and thereby causes cell aging and apoptosis. The anticancer treatment is further proved by in vivo studies. In this way, this design provides a telomeric G-overhang-specific eradication strategy based on a non-G-quadruplex targeting manner.

本研究中使用的阿拉丁产品

204 款产品在本文中被引用